Provided by Tiger Trade Technology Pte. Ltd.

Fulgent Genetics Inc.

19.35
-0.5500-2.76%
Volume:164.51K
Turnover:3.19M
Market Cap:532.42M
PE:-6.89
High:19.89
Open:19.89
Low:19.20
Close:19.90
52wk High:31.04
52wk Low:13.46
Shares:27.52M
Float Shares:16.48M
Volume Ratio:0.74
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8094
EPS(LYR):-1.9700
ROE:-8.11%
ROA:-6.30%
PB:0.53
PE(LYR):-9.82

Loading ...

Fulgent Genetics Inc : Piper Sandler Raises Target Price to $19.00 from $15.00

THOMSON REUTERS
·
Aug 04

Fulgent Genetics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Fulgent Q2 FY26 GAAP Net Loss Widens to $29.5 Million; Revenue Rises to $85.4 Million

Reuters
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

Fulgent Genetics Q2 Adj. EPS $(0.58) Misses $(0.46) Estimate, Sales $85.389M Miss $94.000M Estimate

Benzinga Earnings
·
Jul 31

Fulgent Genetics Q2 Revenue USD 85.389 Million

Reuters
·
Jul 31

Fulgent Genetics Inc: Expects 2026 Revenue $330.0-$340.0 Mln; Non-Gaap Loss of About $2.22-$2.35 Per Share

THOMSON REUTERS
·
Jul 31

Fulgent Genetics Inc Expected to Post a Loss of 46 Cents a Share - Earnings Preview

Reuters
·
Jul 29

Press Release: Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Dow Jones
·
Jul 10

Fulgent Genetics Sets Second-quarter 2026 Results Release and Investor Call

Reuters
·
Jul 10

Fulgent Genetics presents updated FID-007 data at ASCO 2026

TIPRANKS
·
Jun 02

Fulgent posts Phase 2 data: FID-007 plus cetuximab shows 60% ORR in HNSCC

Reuters
·
May 22

Fulgent Announces Rapid Oral Full Abstract Publication for Fid-007 Within the Head and Neck Cancer Track Session at the Asco 2026 Annual Meeting

THOMSON REUTERS
·
May 22

Fulgent Genetics Price Target Cut to $15.00/Share From $30.00 by Piper Sandler

Dow Jones
·
May 06

Fulgent Genetics price target lowered to $15 from $30 at Piper Sandler

TIPRANKS
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Fulgent Genetics Inc : Piper Sandler Cuts Target Price to $15 From $30

THOMSON REUTERS
·
May 05

Foundation Medicine partners with Fulgent Genetics to offer FoundationOne PGx test in US

Reuters
·
May 04

Fulgent Genetics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Fulgent Q1 FY26 net loss widens to $24.8 million; revenue falls to $71.1 million

Reuters
·
May 01